ADMA Biologics Inc EBITDA Margin 2013-2024 | ADMA

ADMA Biologics Inc ebitda margin for the quarter ending September 30, 2024 was 32.38%.

  • ADMA Biologics Inc average ebitda margin for 2023 was 1.24%, a 103.45% increase from 2022.
  • ADMA Biologics Inc average ebitda margin for 2022 was -35.91%, a 60.56% decline from 2021.
  • ADMA Biologics Inc average ebitda margin for 2021 was -91.05%, a 28.77% decline from 2020.

Ebitda margin can be defined as earnings before interest, taxes, depreciation and amortization as a portion of total revenue.

ADMA Biologics Inc EBITDA Margin 2013-2024 | ADMA

  • ADMA Biologics Inc average ebitda margin for 2023 was 1.24%, a 103.45% increase from 2022.
  • ADMA Biologics Inc average ebitda margin for 2022 was -35.91%, a 60.56% decline from 2021.
  • ADMA Biologics Inc average ebitda margin for 2021 was -91.05%, a 28.77% decline from 2020.

Ebitda margin can be defined as earnings before interest, taxes, depreciation and amortization as a portion of total revenue.